I. INTRODUCTION
C ARDIOVASCULAR disease (CVD) affects 37% of the U.S. population and is the leading cause of death in the U.S. [1] . Many key cardiovascular parameters including heart rate (HR), stroke volume (SV), and the pre-ejection period (PEP) have specific applications in the field of CVD monitoring.
HR can be used to monitor arrhythmias that contain irregular beat intervals. An example is atrial fibrillation, which is the most common form of cardiac arrhythmia and increases the risk of stroke and heart failure [2] . As a measure of the heart's pumping ability, SV is an important parameter for congestive heart failure (CHF) patients. The PEP can be used to evaluate ventricular performance in CHF patients, who have an inability to decrease the PEP upon cardiovascular demand and are characterized with a prolonged PEP [3] .
When SV is multiplied with HR, cardiac output (CO) can be obtained, which is defined as the total volume of blood pumped per minute. Because of the heart's reduced pumping ability, CHF patients exhibit decreased CO [3] .
This study uses the site behind the ear as a measurement location. Physiologically, we show that several signals can be measured at the ear location. These signals include the ballistocardiogram (BCG), the electrocardiogram (ECG), and the photoplethysmogram (PPG). Mechanically, the mastoid area behind the ear is rigid, which reduces motion artifacts compared to peripheral locations such as the earlobe and the finger. The ear location is discreet because a small device can be concealed by the ear or hair. Furthermore, as demonstrated by hearing aids and headsets, the ear acts as a natural anchor, allowing device attachment using an ear bud instead of adhesives. The monitor has been tested on 13 healthy subjects in a clinic to verify measured data with clinical grade instrumentation. The proof-of-concept monitor measures the BCG, ECG, and PPG and estimates HR, PEP, SV, CO, and pulse transit time (PTT). This paper is a culmination of our previous work [4] - [7] , with additional results showing a new method for obtaining SV from head BCG. Further studies should be conducted to validate our device on CVD patients.
II. BACKGROUND
The BCG is a noninvasive measurement of the body's mechanical recoil to the blood ejected by the heart during systole. Early work demonstrated that the BCG morphology offers insight into SV, the risk of heart attack, and mortality [8] , [9] . Recently, there is a renewed interest in the BCG [10] - [12] . All of these methods involve a stationary measurement device for nonambulatory monitoring.
To avoid ECG wires from the ear-worn device to the chest, we measure the ECG locally near the ear. The ECG near the ear is significantly attenuated and only R-waves are visible. However, this is sufficient for calculating the RJ interval, which is defined as the interval between the ECG's R-wave and the BCG's J-wave [13] , [14] and has high correlation with the heart's PEP [15] , [16] . PEP can be used to determine left ventricular performance in patients with CVD such as cardiomyopathy and abnormal left ventricular contractions [17] , [18] .
The PPG is generally measured at the finger to maximize signal quality and is usually used to estimate blood oxygenation [19] . We measure the PPG behind the ear at the mastoid above Reid's Baseline. Obtaining HR from the BCG, ECG, and PPG signals can be used for redundancy error checking to ensure high signal quality.
III. METHODS

A. Measuring the Head BCG
To sense the head BCG, we use a 14-bit low noise MEMS triaxial accelerometer (Bosch BMA180 with 150-μG/rtHz noise) that is mounted at the ear. All BCG signals are bandpass filtered from 1 to 10 Hz to remove the gravity contribution and higher frequency artifacts. Fig. 1 shows that the head BCG in the upright standing posture exists in all three axes. The y-axis (headward-footward) is the dominant BCG axis because the blood volume movement is mainly in the y-axis.
To examine the secondary BCG waves, the ensemble average of the head BCG is created by aligning each beat's J-wave and then averaging the beats. As shown in Fig. 2 , the H-, I-, K-, and L-waves become visible in the ensemble average.
Because the head BCG is in the range of 10 mG, it can only be measured in states of relative rest. However, for the target application of long-term wearable monitoring, numerous measurement periods exist throughout the day when the wearer is at less than 4 mG of acceleration [16] .
B. Measuring the Head ECG
To sense the ECG at the head, one electrode is placed on the mastoid area, and the second electrode is placed on the posterior upper middle neck. The mastoid's bony structure and the neck's flat surface provide a stable electrode contact. Together, the two electrodes measure a single-lead ECG.
Usually, a third driven-right-leg (DRL) electrode is used for common-mode interference rejection as well as feedback to set the DC potential of the body. However, this DRL electrode is omitted because of the limited area near the ear. As a result, a digital filter removes powerline interference. The ECG front-end circuit is shown in Fig. 3 .
Using AgCl gel electrodes, Fig. 4 shows ECG measurements taken from the chest (lead II, 15 cm apart, gain of 250) and from the left mastoid area (4 cm apart, gain of 7000).
As seen in Fig. 4 , the ECG measured at the mastoid area is in the range of 30 μVpp, which is two orders of magnitude less than the standard chest ECG. This attenuation is due to the pattern of the ECG field lines at the head, which yield a very small potential difference when projected onto the mastoid lead. Because of this attenuation, the head ECG has a poor signal-tonoise ratio (SNR) and only R-waves are immediately visible.
C. Extracting the RJ Interval
To extract the RJ interval, the simplest method is to use a peak detection algorithm to determine the delay between the ECG's R-wave and the BCG's J-wave. However, as shown in Fig. 5(a) , the BCG and the ECG signals at the head have low SNRs where a peak detection algorithm is prone to error. Instead, cross correlation is proposed as a noise tolerant method for determining the RJ interval. This method takes advantage of the fact that both head BCG and head ECG waveforms have a similar morphology and are phase-locked to a lag index equal to the RJ interval.
To demonstrate this, Fig. 5(b) shows a time segment of the head ECG signal cross-correlated with a simultaneous head BCG signal. The highest peak of the cross-correlation result occurs when the ECG's R-wave and the BCG's J-wave coincide during time-shifting. As expected, the lag index of the highest cross-correlation peak is the RJ interval.
To reduce the amount of computation, the cross correlation can be limited to a lag range of 0.1-0.3 s because the RJ interval is physiologically within this range [21] . This range is shown as the shaded region in Fig. 5(b) . For example, if the time window is 8 s long, then this 0.2-s truncation allows a 97.5% computational saving compared to a complete cross correlation. Another benefit of this truncation is that it removes nearby cross-correlation peaks from consideration, thus improving peak confidence. In the clinical test analysis, a window length of 8 s is chosen to reliably extract the RJ intervals.
D. Measuring the Head PPG
PPG signals at the head are obtained with a sensor operating in reflectance mode instead of transmission mode. In reflectance mode, the LEDs shine light into the body, and the backscattered light from tissue, blood, and bone is received by photodiodes in the same plane as the LED. Several new challenges arise in reflectance-mode PPG. First, the mechanical housing of the sensor may not be sufficient for blocking ambient light from the PDs; therefore, care must be taken when sampling and filtering to avoid aliasing interferers into the PPG bandwidth of interest. Second, reflectance-mode measurements are often part of wearable systems, which require low-power and low-voltage operation to reduce the battery size and optimize the form factor. To help mitigate these issues, the wearable vital signs monitor uses a dynamic range enhancement circuit to lower the voltage of the PPG front end and reduce the resolution requirements of the analog-to-digital converter [7] , [20] .
Head PPG signals are similar to PPG signals obtained by transmission through the finger, as shown in Fig. 6 . The morphological differences are due to the vascular transmission line, which sends the pulse from the heart to the head, compared to the finger.
E. Device Design
The wearable device measures the BCG and the ECG at the head and sends the data wirelessly to a computer for visualization, recording, and analysis. The device is shown in Fig. 7 and the system block diagram is shown in Fig. 8 .
The microcontroller (MSP430) continuously samples the BCG and the ECG sensors at 155 Hz and sends the data to a 2.4-GHz low-power wireless transceiver (CC2500). The power management circuit draws power from a single 3-V 220-mAh lithium coin cell battery (CR2032). The computer interface consists of a CC2500 transceiver and a MSP430 microcontroller, which sends the received data to the computer's USB port. The computer records, plots, and filters the BCG and the ECG data in real time using MATLAB.
A modified hearing aid housing manufactured by Taising Hearing Amplifier Ltd. mechanically supports the PCB's. The device is anchored to the ear using the attached earbud. Two ECG electrodes are attached to the mastoid and the neck using AgCl gel electrodes. Table I contains the important system parameters.
F. Failure Cases
The ear-worn vital signs monitor measures signals with low SNR, such as the BCG. In order to obtain measurements that are uncorrupted, the user should be relatively sedentary. If the user is moving, then the data are unusable. To avoid reporting erroneous data, the accelerometer could be used to detect when the user is sedentary and then take the physiological measurements. Previous studies have shown that users have several windows throughout the day where acceleration is less than 4 mG [16] . Additionally, checking that all three physiological signals measure the same HR can also be used to ensure that the data are not corrupted.
G. Human Subjects Study
Clinical testing was conducted at MIT's Clinical Research Center, and the protocol was approved by MIT's Institutional Review Board. The protocol begins by consenting a subject, followed by a health questionnaire to ensure the subject had no prior cardiovascular conditions. Reference equipment was then attached to the subject, which included a Criticare 504-US chest ECG (lead II configuration) and finger pulse oximeter, a Sonosite BioZ Dx impedance cardiography (ICG) machine for measuring PEP and CO, and a Finapres Portapres for continuous blood pressure measurements. Instrumentation was completed when the wearable vital signs monitor was attached to the left ear of the subject. The test was performed on 13 healthy subjects, consisting of ten male subjects and three female subjects. The subjects varied from 25 years old to 63 years old (mean 39.7, std 14.2), 1.55-1.93 m in height (mean 1.77 m, std 0.097 m), and 49.9-103 kg in weight (mean 74.8 kg, std 12.9 kg). Fig. 9 shows a screen shot of the wearable monitor collecting data simultaneously for a single user.
IV. HUMAN SUBJECT STUDY RESULTS AND DISCUSSION
A. Stroke Volume J-wave amplitudes are extracted from 20-beat ensemble averages in the standing posture from each subject. Fig. 10 plots J-wave amplitudes versus SVs from 13 subjects. A linearly proportional relationship between J-wave amplitudes and SVs is observed because the BCG recoil is directly related to the mass (or volume) of the pumped blood. It is important to note that our study was limited to healthy patients who did not have vessel diseases that could confound the BCG to SV results. A larger study is required to assess the overall BCG to SV relationship. Nevertheless, our data showed an R 2 correlation of 0.66.
B. Pre-Ejection Period
The Valsalva maneuver is designed to induce a temporary increase in the subjects' PEP. The RJ interval is extracted by cross-correlating the wearable device's BCG and ECG, while the reference PEP is measured using the ICG machine. Fig. 11 shows an example of measured RJ interval and PEP from a subject who performs a Valsalva maneuver from 43 to 63 s. The decreased venous return and ventricular filling volume during Valsalva lead to a prolonged PEP. The PEP's increase of 30 ms corresponds to an equal increase in the RJ interval during the strain.
It is observed that the RJ interval is always longer than the PEP by an offset duration that is subject dependent. This is because the opening of the aortic valve marks the end of the PEP, while the J-wave occurs when the blood is accelerating after exiting Fig. 12 . Beat-to-beat RJ interval (from device) and PEP (from ICG) among seven subjects during 28 tilt maneuvers. Fig. 13 . Bland-Altman representation of the beat-to-beat RJ interval and PEP from the same dataset used in Fig. 12. the heart. This offset is affected by variables such as body height and blood pressure, thus making it subject dependent. Fig. 12 plots the beat-to-beat RJ interval versus the PEP after removing the subject-dependent RJ interval-PEP offsets. The data consists of 28 tilt maneuvers from seven subjects with 2258 beats. The remaining six subjects had faulty PEP measurements, as the ICG machine was unable to detect aortic valve openings. From the data, we observe that the RJ interval exhibits a nearly one-to-one linear dependence on the PEP with a slope of 0.96 and an R 2 value of 0.96. A Bland-Altman representation of the data is shown in Fig. 13 , where the standard deviation in differences between the beat-to-beat RJ interval and PEP is 9.6 ms for seven subjects.
C. Utilizing the BCG for PTT Measurements
It has been documented that the PEP is a large error source when estimating blood pressure from transit time measurements [22] . Compared to measurements that use the R-wave of the ECG to the peak of the derivative of the PPG, called pulse arrival time, PTT using the J-wave of the BCG removes the PEP from the measurement. This increases the accuracy of PTT-to-BP algorithms as the PEP is not constant and does not always correspond appropriately to changes in pressure [7] , [22] .
V. CONCLUSION
This study has identified periodic head movements as a type of BCG, which is shown to closely resemble the traditional BCG waveform after ensemble averaging. One direct application of the head BCG is electrode-less HR monitoring. Another application is the estimation of SV based on the BCG amplitude. When the BCG is used in conjunction with the ECG, the RJ interval can be extracted using cross correlation and is shown to linearly correlate with the PEP. When the BCG is used in conjunction with the PPG, PTT can be measured, which is theoretically correlated with blood pressure.
